For years, researchers have debated whether the enzyme lipoprotein-associated phospholipase A2 (Lp-PLA2), produced by inflammatory cells, is a 'good guy' or 'bad guy' in atherosclerosis. Work in pigs provides strong support for the view that Lp-PLA2 promotes the formation of atherosclerotic lesions and dangerous, unstable atherosclerotic plaques (pages 1059–1066).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events
Diabetologia Open Access 25 September 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Glass, C.K. & Witztum, J.L. Cell 104, 503–516 (2001).
Tabas, I., Williams, K.J. & Boren, J. Circulation 116, 1832–1844 (2007).
Shah, P.K. Curr. Opin. Lipidol. 18, 492–499 (2007).
Wilensky, R.L. et al. Nat. Med. 14, 1059–1066 (2008).
Kolodgie, F.D. et al. Arterioscler. Thromb. Vasc. Biol. 26, 2523–2529 (2006).
Packard, C.J. et al. N. Engl. J. Med. 343, 1148–1155 (2000).
Garza, C.A. et al. Mayo Clin. Proc. 82, 159–165 (2007).
Stafforini, D.M., Prescott, S.M. & McIntyre, T.M. J. Biol. Chem. 262, 4223–4230 (1987).
Tjoelker, L.W. et al. Nature 374, 549–553 (1995).
Zalewski, A. & Macphee, C. Arterioscler. Thromb. Vasc. Biol. 25, 923–931 (2005).
Gardner, A.A., Reichert, E.C., Topham, M.K. & Stafforini, D.M. J. Biol. Chem. 283, 17099–17106 (2008).
Mohler, E.R. III et al. J. Am. Coll. Cardiol. 51, 1632–1641 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Webb, N. Getting to the core of atherosclerosis. Nat Med 14, 1015–1016 (2008). https://doi.org/10.1038/nm1008-1015
Issue Date:
DOI: https://doi.org/10.1038/nm1008-1015